ABC | Volume 110, Nº1, January 2018

Original Article Santos et al Development and psychometric validation of HIPER-Q Arq Bras Cardiol. 2018; 110(1):60-67 Table 1 – Socioeconomic and clinical characteristics of hypertensive patients (n = 184) and HIPER-Q ratings (median and interquartile range) according to these characteristics Variable Category n(%) HIPER-Q score Median (IR) p † Sex Male 123(66.8) 25 (10) 0.033* Female 61(33.2) 27 (8.5) Comorbidities CAD 149(81) 25 (8.5) 0.033* Dyslipidemias 149(81) 25 (8.5) 0.127 Myocardial infarction 127(69) 24 (8) 0.003* Diabetes Mellitus 52(28.3) 25 (10) 0.493 POAD 24(13) 27 (10) 0.805 Stroke 23(12.5) 26 (11) 0.928 Smoking 03(1.6) 26 (0.0) 0.998 COPD 02(1.1) 35 (0.) 0.539 Cardiologic procedures Angioplasty 116(63) 24 (7.5) 0.019* Cardiac surgery 53(28.8) 23 (8) 0.275 Classes of antihypertensive drugs ACEI 65(35.3) 28 (10.5) 0.768 α and β adrenergic blockers 56(30.4) 28 (10.75) 0.186 Angiotensin II receptor antagonists 52(28.3) 25 (9) 0.669 Diuretics 21(11.4) 27 (14) 0.820 Calcium channel blockers 05(2.7) 29 (17) 0.195 Unknown 15(8.2) 22 (7.75) 0.755 Number of anti- hypertensive drugs 0 37(20.1) 22 (7) 0.993 1 108(58.7) 26 (10) 2 36(19.6) 28 (9.75) 3 2(1.1) 23 (0.0) Type of rehabilitation Public 162(88) 25 (9) 0.274 Private 22(12) 32.5 (10.25) Time of rehabilitation From 01 to 06 months 105(47.3) 26 (9) 0.317 From 06 to 12 months 10(4.5) 22 (14.25) From 12 to 24 months 17(7.7) 27 (10) Over 24 months 51(23) 27 (10) Family income (salary) < 01 09 (4.9) 22 (8.5) 0.023* 01 - 05 94(51.1) 25.5 (9) 05 - 10 42(22.8) 26 (8) 10 - 20 32(17.4) 31 (14.5) > 20 07(3.8) 35 (11) Educational level Never went to school 08(4.3) 20 (8.75) 0.002* Some primary education 59(32.1) 25 (7) Completed primary 20(10.9) 27 (6.5) Some high school 16(8.7) 22.5 (4.75) Completed high school 35(19) 27 (11) Some college 13(7.1) 31 (14) Completed college 30(16.3) 31.5 (14.25) Graduate degree 3(1.6) 36 (0.0) IR: interquartile range; CAD: coronary artery disease; POAD: peripheral obstructive arterial disease; COPD: chronic obstructive pulmonary disease;ACEI: angiotensin converting enzyme inhibitors † chi-square; * p < 0.05. 63